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Electrospray ionization (ESI) tandem mass spectrometry (MS) has simplified analysis of
phospholipid mixtures, and, in negative ion mode, permits structural identification of
picomole amounts of phospholipid species. Collisionally activated dissociation (CAD) of
phospholipid anions yields negative ion tandem mass spectra that contain fragment ions
representing the fatty acid substituents as carboxylate anions. Glycerophosphocholine (GPC)
lipids contain a quaternary nitrogen moiety and more readily form cationic adducts than
anionic species, and positive ion tandem mass spectra of protonated GPC species contain no
abundant ions that identify fatty acid substituents. We report here that lithiated adducts of
GPC species are readily formed by adding lithium hydroxide to the solution in which
phospholipid mixtures are infused into the ESI source. CAD of [MLi1] ions of GPC species
yields tandem mass spectra that contain prominent ions representing losses of the fatty acid
substituents. These ions and their relative abundances can be used to assign the identities and
positions of the fatty acid substituents of GPC species. Tandem mass spectrometric scans
monitoring neutral losses of the head-group or of fatty acid substituents from lithiated adducts
can be used to identify GPC species in tissue phospholipid mixtures. Similar scans monitoring
parents of specific product ions can also be used to identify the fatty acid substituents of GPC
species, and this facilitates identification of distinct isobaric contributors to ions observed in
the ESI/MS total ion current. (J Am Soc Mass Spectrom 1998, 9, 516–526) © 1998 American
Society for Mass Spectrometry
Phospholipids are essential components of cellularmembranes [1], and distinct molecular species aredifferentially distributed among tissues and
within subcellular compartments [2–5]. The phospho-
lipid composition of cell membranes influences their
fusion with other membrane compartments [6, 7] and
cell growth and death [8]. Hydrolysis of phospholipid
molecules to yield second messenger substances is
involved in transduction of signals from the extracellu-
lar to the intracellular environment [9–14], and transfer
of fatty acid moieties among phospholipid classes is
complex and regulated [8, 15–17]. Sensitive analytical
methods to identify components of phospholipid mix-
tures may facilitate the study of processes governing
the distribution of distinct phospholipid molecular spe-
cies at biologic loci, particularly with membranes ob-
tainable only in small quantities from specialized cells
or intracellular compartments [4, 5].
Glycerophospholipids contain a glycerol backbone,
and, in the sn-3 position, bear a phosphodiester moiety
linked to a polar head-group, such as choline, ethanol-
amine, serine, inositol, or glycerol [18]. Fatty acid moi-
eties are esterified to the sn-2 and often the sn-1
positions of the glycerol backbone, although ether link-
ages to fatty alcohol or aldehyde residues may also
occur in the sn-1 position [18]. Fatty acid residues of
various chain lengths and degrees of unsaturation may
be distributed symmetrically or asymmetrically in the
sn-1 and sn-2 positions, resulting in complex biological
phospholipid mixtures. Conventional methods for de-
termining identities and abundances of components of
phospholipid mixtures involve multiple steps [4, 5, 15,
19]. One approach involves normal phase high perfor-
mance liquid chromatography (HPLC) analysis to sep-
arate phospholipid head-group classes and then reverse
phase HPLC analysis to separate molecular species [19].
Each isolated species is subjected to solvolysis to yield
products from fatty acid, alcohol, or aldehyde moieties,
and these components are derivatized and analyzed by
gas chromatography/mass spectrometry (GC/MS) [4,
5, 15]. This complex procedure may result in analyte
losses during each processing step and in ambiguous
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assignments when HPLC separation of molecular spe-
cies is incomplete.
Fast atom bombardment (FAB)/MS permits direct
analysis of phospholipids as intact molecules [18, 20–
25], thereby circumventing solvolysis and derivatiza-
tion. When combined with collisionally activated disso-
ciation (CAD) and tandem mass spectrometry, FAB
permits direct identification of phospholipid molecular
species [18]. The sensitivity of FAB/MS is limited by
matrix-derived background ions, and this precludes its
application to some biological phospholipid mixtures
obtainable in only small quantities [4, 5]. Electrospray
ionization (ESI) offers greater sensitivity than FAB for
phospholipid analysis, and ESI/MS/MS permits iden-
tification of picomole quantities of phospholipid species
in biological mixtures [26–29].
The tandem mass spectra produced by CAD of
phospholipid ions are similar when ionization is
achieved by FAB or by ESI [18, 27]. Glycerophospho-
lipid species which contain head-groups (e.g., ethanol-
amine, serine, inositol, or glycerol) that readily form
anions yield negative ion tandem mass spectra that
identify the fatty acid substituents [18, 27]. Each sub-
stituent is represented by its carboxylate anion, and the
relative abundances of these ions reflect the positions of
the substituents [18, 27]. Glycerophosphocholine (GPC)
species are the most abundant constituents of mamma-
lian cell membranes, contain a quaternary nitrogen with
a fixed positive charge, and more readily form positive
than negative ions. Positive ion tandem mass spectra of
protonated adducts of GPC species are dominated by
phosphocholine ion and contain no abundant ions that
identify the fatty acid substituents [18, 27].
In FAB, negative ions are formed from GPC species
by loss of methyl substituents from the quaternary
nitrogen, loss of trimethylamine, and loss of the choline
moiety [18, 30]. CAD of these ions yields tandem mass
spectra that permit assignments of the identities and
positions of fatty acid substituents [18, 30]. The modest
intensity of such ions in negative ion ESI/MS analyses
of GPC species has caused examination of chloride
adducts of GPC species, and CAD of [MCl2] ions yields
tandem mass spectra that contain carboxylate anions of
the fatty acid substituents [28]. The [35Cl]/[37Cl] isoto-
pic distribution complicates interpretation of ESI/MS
surveys of components of tissue GPC mixtures because
the molecular weights of individual GPC species may
differ by 2 u, owing to a difference of a single degree of
carbon–carbon unsaturation in the fatty acid substitu-
ents. Analysis of GPC species by continuous flow liquid
secondary ion mass spectrometry in negative ion mode
has also been reported to yield less signal than analysis
of cationic adducts in positive ion mode [31].
We report here that lithiated adducts of GPC species
can be readily analyzed by positive ion ESI/MS, and
that CAD of these adducts yields tandem mass spectra
that contain ions reflecting the identities and positions
of the fatty acid substituents.
Materials and Methods
Materials
Standard GPC species with defined fatty acid sub-
stiutents were obtained from Avanti Polar Lipids (Bir-
mingham, AL). Solvents were obtained from Burdick
and Jackson (Muskegee, MI). Lithium salts were ob-
tained from Sigma Chemical Co. (St. Louis, MO). Male
Sprague Dawley rats were obtained from Harlan (Indi-
anapolis, IN) and fed with Rodent Chow 5001 (Ralston
Purina, St. Louis, MO).
Preparation of Tissue Phospholipid Extracts
Male Sprague-Dawley rats (200–250 g body weight)
were anesthetized by intraperitoneal injection of so-
dium pentobarbital (45 mg/kg). When corneal reflexes
were absent, the abdomen was incised and the liver
removed and placed in ice-cold phosphate-buffered
saline (PBS). The top of the cranium was removed and
the brain excised and placed in ice-cold PBS. Tissue
samples were rinsed twice in ice-cold PBS and minced.
Minced tissue (1 g wet weight) was suspended in a
solution (2 mL) of chloroform/methanol (1/1, v/v) and
homogenized with a Tissue-Tearor (setting 7, 1 min,
Biospec Products, Bartlesville, OK). Homogenates were
sonicated on ice with a Vibra Cell probe sonicator
apparatus (20% power, 5 s bursts, 1 min, Sonics and
Materials, Danbury, CT). Samples were centrifuged
(2800 3 g, 5 min) to remove tissue debris. Supernatants
were transferred to silanized glass tubes and extracted
[32] by adding methanol (1 mL), chloroform (1 mL), and
water (1.8 mL). Samples were vortex mixed and centri-
fuged (900 3 g, 5 min). Supernatants were removed,
concentrated to dryness under nitrogen, and reconsti-
tuted as specified below.
Mass Spectrometry
ESI/MS analyses were performed on a Finnigan (San
Jose, CA) TSQ-7000 triple stage quadrupole spectrom-
eter equipped with an ESI source and controlled by
Finnigan ICIS software operated on a DEC alpha work-
station. Solutions of standard phospholipids or tissue
extracts were dissolved in methanol/chloroform (90/
10) at final concentrations of about 1 pmol/mL. To form
lithiated adducts of GPC species, LiOH (2 nmol/mL
final concentration) was added to this solution. Samples
were infused (1 mL/min) into the ESI source with a
Harvard syringe pump. The electrospray needle and
the skimmer were at ground potential and the electro-
spray chamber and the entrance of the glass capillary at
4.4 kV. The heated capillary temperature was 250°C. For
collisionally activated dissociation (CAD) and tandem
mass spectrometry, the collision gas was argon (2.2–2.5
mtorr), and collision energies were varied between 32
and 36 eV. Product ion spectra were acquired using a
signal-averaging protocol in profile mode at a rate of 1
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scan per 3 s. In some cases, neutral loss scans were
performed to identify parent ions that yielded product
ions that had undergone losses of 59, 183, or 189 from
the mass-to-charge ratio value of the parent ion. In
other cases, parent ions were identified that yielded
product ions of a specific mass-to-charge ratio value,
e.g., m/z 397, 425, 453, 451, 449, 473, or 497. It was
found that lithiated adducts of GPC species could also
be formed by adding lithium acetate, lithium chloride,
or lithium fluoride to the infusion solution. With lith-
ium acetate, [MLi1166] ions were observed in addition
to [MLi1] ions. Tandem mass spectra of [MLi1166] ions
indicated that they represented lithium acetate adducts
of [MLi1] ions. These adduct ions constituted up to 30%
of the total ion current. With lithium chloride and
lithium fluoride, [MH1] ions were observed in addition
to [MLi1] ions.
Results
The positive ion ESI/MS/MS spectra of cationic ad-
ducts of synthetic standard GPC species containing
symmetrical sn-1 and sn-2 fatty acid substituents were
determined first. As illustrated in Figure 1A, the CAD
of the [MH1] ion (m/z 734) of dipalmitoyl-GPC [(16:
0/16:0)-GPC] yields a tandem mass spectrum domi-
nated by an ion at m/z 184 ([H2PO4(CH2)2N(CH3)3]
1).
This spectrum contains no abundant ions that identify
fatty acid substituents, concordant with previous re-
ports on the tandem mass spectra of protonated GPC
species generated by FAB or ESI [18, 20–23, 27]. In
contrast, the lithiated adduct of (16:0/16:0)-GPC exhib-
its a more complex fragmentation pattern upon CAD
(Figure 1B). CAD of the [MLi1] ion (m/z 740) results in
neutral loss of trimethylamine (MLi1 2 59) to yield an
ion at m/z 681. Ions at m/z 557 (MLi1 2 183) and m/z
551 (MLi1 2 189) are presumed to reflect net, though
probably not direct, loss of [HPO4(CH2)2N(CH3)3] or of
[LiPO4(CH2)2N(CH3)3], respectively. Subsequent spec-
tra indicate that losses of 59, 183, and 189 are common
to the tandem spectra of all GPC-Li1 species, regardless
of the nature of the fatty acid substituents, and the
possible genesis of these losses is discussed further
below. Ions resulting from these losses reflect the phos-
phocholine head-group but do not yield information
about fatty acid substituents.
The CAD spectrum of (16:0/16:0)-GPC-Li1 (Figure
1B) also contains ions at m/z 484, m/z 478, and m/z 425
(Figure 1B), which may reflect neutral losses of palmitic
acid (MLi 2 256), of the lithium salt of palmitate (MLi 2
262), and of trimethylamine plus palmitic acid (MLi 2
315), respectively. In addition, an ion at m/z 239 may
represent the acylium ion derived from palmitate.
These assignments are supported by the tandem spec-
trum obtained by CAD of the [MLi1] ion (m/z 684) of
dimyristoyl-GPC [(14:0/14:0)-GPC] (Figure 1C). This
spectrum contains ions at m/z 456, m/z 450, and m/z
397, which are consistent with neutral loss of myristic
acid (MLi 2 228), of the lithium salt of myristate (MLi 2
234), and of trimethylamine plus myristic acid (MLi 2
287), respectively. The acylium ion (m/z 211) derived
from myristate is also observed (Figure 1C).
The behavior of a standard GPC species with asym-
metrical fatty acid substituents was examined next.
CAD of the [MLi1] ion (m/z 816) of (1-stearoyl,
2-arachidonoyl)-GPC [(18:0/20:4)-GPC] yields a tan-
dem mass spectrum (Figure 1D) which contains ions
consistent with neutral losses of trimethylamine plus
either the sn-1 fatty acid substituent (MLi1 2 343) or the
sn-2 substituent (MLi1 2 363) as free fatty acids at m/z
473 and m/z 453, respectively. The former ion is more
abundant than the latter, suggesting that the relative
abundance of ions reflecting these losses may indicate
the positions of the fatty acid substituents, as discussed
further below. Figure 1D also illustrates that neutral
losses of the sn-1 fatty acid substituent as a free fatty
acid (MLi1 2 284) or as a lithium salt (MLi1 2 290) are
also observed at m/z 532 and m/z 526, respectively. In
addition, neutral losses of the sn-2 fatty acid substituent
as a free fatty acid (MLi1 2 304) or as a lithium salt
(MLi1 2 310) are observed at m/z 512 and m/z 506,
respectively.
A prominent ion (m/z 341, MLi1 2 475) in the
tandem spectrum (Figure 1D) of (18:0/20:4)-GPC-Li1 is
Figure 1. Positive ion ESI tandem mass spectra of cationic
adducts of standard glycerophosphocholine species. Panels are
tandem mass spectra obtained from CAD of the [MH1] ion of
dipalmitoyl-GPC (panel A), the [MLi1] ion of dipalmitoyl-GPC
(panel B), the [MLi1] ion of dimyristoyl-GPC (panel C), or the
[MLi1] ion of (1-stearoyl, 2-arachidonoyl)-GPC (panel D).
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consistent with net, though probably not direct, elimi-
nation of [LiPO4(CH2)2N(CH3)3] and loss of the sn-2
substituent as a substituted ketene. An analogous and
similarly prominent (MLi1 2 475) ion is observed in the
tandem mass spectrum of the lithiated adduct of stan-
dard (1-palmitoyl, 2-arachidonoyl)-GPC [(16:0/20:4)-
GPC] (not shown). No analogous ions of comparable
abundance are observed in the tandem spectra of GPC
species, which contain sn-2 substituents with less than
three carbon–carbon double bonds, suggesting that net
elimination of [LiPO4(CH2)2N(CH3)3] and the sn-2 sub-
stituent as a ketene requires a polyunsaturated sn-2
substituent. No prominent acylium ions are observed in
the tandem spectrum of (18:0/20:4)-GPC-Li1 (Figure
1D), and subsequent spectra suggest that acylium ions
may be formed preferentially with saturated sn-2 fatty
acid substituents and less readily with sn-1 substituents
or with unsaturated fatty acids.
The two most abundant ions in the spectra in Figure
1B, C, D are [MLi1 2 189] and [MLi1 2 183]. Formation
of these ions may involve initial loss of trimethylamine
and formation of an intermediate structure containing a
five-membered cyclophosphane moiety, as illustrated
in Figure 2. The cyclophosphane moiety may then be
eliminated as a neutral lithium salt to yield the [MLi1 2
189] ion depicted in pathway 1 (Figure 2). Isomeric
structures for the [MLi1 2 189] ion could also result
from pathways similar to those in pathway 1. Alterna-
tively, the cyclophosphane may be eliminated as the
neutral species depicted in pathway 2 (Figure 2) to yield
the [MLi1 2 183] ion. A variation on pathway 2 is that
the diglyceride-like moiety could be eliminated as a
neutral species. In that case, the charged species result-
ing from the elimination would be a lithiated cyclo-
phosphane with an m/z value of 131. An ion with that
mass-to-charge ratio value, although of low abundance,
is observed in the spectra in Figure 1B, C, D. Pathways
similar to those in Figure 2 (pathways 1 and 2) have
been used to rationalize head-group eliminations from
sodiated GPC species [27].
Among the more abundant ions in the spectra in
Figure 1B, C, D that yield information about the fatty
acid substituents are the [MLi1 2 59 2 RxCOOH] ions,
and they may also arise (via pathways 3 and 4, respec-
tively) from the intermediate structure resulting from
initial loss of trimethylamine depicted in Figure 2.
Losses like those in pathways 3 and 4 could also occur
directly from the [MLi1] ion to yield the [MLi1 2
RxCOOH] ions observed in the spectra in Figure 1B, C,
D. The mechanisms for fatty acid elimination depicted
in pathways 3 and 4 (Figure 2) have been used to
rationalize elimination of fatty acids from other phos-
pholipid ions [18]. The pathways in Figure 2 are con-
sistent with tandem mass spectra obtained from CAD of
the [MLi1] ions of two deuterated analogs of (14:0/14:
0)-GPC. These analogs contained either four deuterium
atoms on the methylene moieties of the choline group
or nine deuterium atoms on the methyl substituents of
the quaternary amine. Table 1 contains the mass-to-
charge ratio values and relative abundances of the ions
summarized in Figure 2 for native (14:0/14:0)-GPC and
for the two deuterated analogs. In each case, the mass-
to-charge ratio values for these ions shifted or failed to
shift in the manner expected from the pathways in
Figure 2 and from the location of the deuterium atoms.
This was also true for the mass-to-charge ratio value of
the ion thought to represent the lithiated cyclophos-
phane moiety (Table 1, last column).
To determine whether the relative abundances of
ions reflecting losses of the fatty acid substituents from
lithiated GPC species might indicate the positions of
these substituents, two sets of positional isomers of
synthetic standard GPC species were examined (Figure
3). The first set was (14:0/16:0)-GPC (Figure 3A) and
(16:0.14:0)-GPC. (Figure 3B). CAD of the [MLi1] ions
(m/z 712) of these compounds yielded tandem spectra
that contained ions reflecting loss of myristic acid (m/z
484), of the lithium salt of myristate (m/z 478), of
palmitic acid (m/z 456), of the lithium salt of palmitate
(m/z 450), and of trimethylamine plus either myristic
acid (m/z 425) or palmitic acid (m/z 397). Compari-
son of the relative abundances of the ions at m/z 425
Figure 2. Proposed pathways for generation of five informative
ions in the tandem mass spectra of lithiated adducts of glycero-
phosphocholine lipids. The pathways are proposed to rationalize
[MLi1 2 59] (initial step), [MLi1 2 189] (pathway 1), [MLi1 2 183]
(pathway 2), [MLi1 2 59 2 R1CO2H] (pathway 3), and [MLi
1 2
59 2 R2CO2H] (pathway 4) ions observed in the tandem mass
spectra of GPC-Li1 adducts.
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and 397 in Figure 3A, B indicates that the abundance of
the ion reflecting loss of trimethylamine plus the sn-1
substituent exceeds that of the ion reflecting loss of
trimethylamine plus the sn-2 substituent.
That phenomenon is further illustrated with a sec-
ond set of positional isomers of GPC standards, (16:0/
18:1)-GPC (Figure 3C) and (18:1/16:0)-GPC (Figure 3D).
CAD of the [MLi1] ions (m/z 766) of these compounds
yields tandem mass spectra that contain ions reflecting
losses of palmitic acid (m/z 510), of the lithium salt of
palmitate (m/z 504), of oleic acid (m/z 484), of the
lithium salt of oleate (m/z 478), and of trimethylamine
plus either palmitic acid (m/z 451) or oleic acid (m/z
425). Comparison of the relative abundances of the ions
at m/z 425 and 451 in Figure 2C, D again indicates that
the abundance of the ion reflecting loss of trimethyl-
amine plus the sn-1 substituent exceeds that of the ion
reflecting loss of trimethylamine plus the sn-2 substitu-
ent. Similar behavior was observed with lithiated ad-
ducts of all other asymmetrical standard GPC species
that were examined (Table 2).
Because the loss of one fatty acid substituent yields a
fragment ion structure that retains the other fatty acid
substituent, tandem mass spectrometric scanning for
parents of such fragment ions can be used to identify
the fatty acid substituents of lithiated GPC species in
mixtures. Similar information can be obtained by scan-
ning for parents that undergo neutral losses of fatty
acids or their lithium salts with or without loss of
trimethylamine. Table 3 summarizes the fragment ions
resulting from these losses for parent GPC-Li1 ions that
contain specific fatty acid substituents. Similar tandem
mass spectrometric scans monitoring losses of 59 (trim-
ethylamine), 183 (net loss of [HPO4(CH2)2N(CH3)3]), or
189 (net loss of [LiPO4(CH2)2N(CH3)3]) can be used to
identify parent ions which contain the phosphocholine
head-group in lipid mixtures. Although ions reflecting
these losses are observed in the tandem mass spectra of
all GPC-Li1 species examined, their relative abun-
dances are affected by the fatty acid substituents. The
ratio for the abundance of the (MLi1 2 183) ion divided
by that of the (MLi1 2 189) ion increases with the
degree of unsaturation of the sn-2 substituent and is
about 0.5 for (16:0/16:0)-GPC-Li1 and about 5 for
(18:0/20:4)-GPC-Li1 (Figure 1).
The potential utility of forming lithiated adducts to
identify GPC species in tissue phospholipids was exam-
ined next. Various GPC species in extracts of phospho-
lipids from rat liver exhibited similar apparent relative
abundances when examined by ESI/MS in positive ion
mode as either protonated (Figure 4A) or lithiated
(Figure 4B) adducts. The ESI/MS profile of lithiated
GPC adducts was also similar when phospholipid ex-
tracts from liver were compared to NP-HPLC-purified
GPC species (not shown). The ESI/MS profile of GPC
species contained in phospholipid extracts from rat
brain (Figure 4C) differed from that of the GPC species
from rat liver (Figure 4B) when the molecules in both
extracts were examined as lithiated species. This illus-
trates that different tissues within the same organism
express some common GPC species with different rel-
ative abundances, as reflected, for example, by the
different relative intensities of the ion at m/z 788 in
Figure 4B, C. Some GPC species that are prominent
components of one tissue are virtually absent from
another, as indicated by comparing the abundance of
the ion at m/z 740 in Figure 4B, C.
That all of the major species visualized in the total
positive ion current of the crude rat liver phospholipid
extract (Figure 4B) contained the phosphocholine head-
group was confirmed by scanning for parents which
undergo losses of the head-group or a component of it
(Figure 5). Such losses included 183 (Figure 5A), 189
(Figure 5B), and 59 (Figure 5C). The differing apparent
relative abundances of various parents in the scans in
Figure 5A, B reflect the influence of fatty acid compo-
sition on the losses of 183 and 189, as discussed above.
The intensity of the ion reflecting loss of trimethylamine
(Figure 5C) also varies among different molecular spe-
cies with a phosphocholine head-group and appears to
be especially favored in sphingomyelin (SM) species.
This accounts for the appearance of prominent ions at
m/z 709 (16:0-SM) and m/z 737 (18:0-SM) in the
spectrum in Figure 5C even though ions with these
Table 1. Summary of fragment ions reflecting net losses of trimethylamine, of the entire head group, or of trimethylamine plus the
fatty acid substituent observed in CAD tandem mass spectra of lithiated species of standard glycerophosphocholine lipids with
isotopes of hydrogen at various positions in the head group
No. GPC species MLi1
Fragment ions from losses of A through Da
(C[XH2])2PO4HLi
1A B C D
m/z (ra) m/z (ra) m/z (ra) m/z (ra) m/z (ra)
(1) 14:0/14:0-GP-(CH2)2N(CH3)3 684 625 (02) 501 (32) 495 (100) 397 (35) 131 (05)
(2) 14:0/14:0-GP-(CD2)2N(CH3)3 688 629 (03) 501 (48) 495 (100) 401 (35) 135 (07)
(3) 14:0/14:0-GP-(CH2)2N(CD3)3 693 625 (02) 501 (34) 495 (100) 397 (21) 131 (06)
aIdentification of losses A through D: A 5 N(C[yH3])3, B 5 HPO4(C[
xH2])2N(C[
yH3])3, C 5 HPO4(C[
xH2])2N(C[
yH3])3, D 5 A1RCO2H. For compound No.
(1), x 5 1 and y 5 1. For compound No. (2), x 5 2 and y 5 1. For compound No. (3), x 5 1 and y 5 2.
CAD tandem spectra were obtained using a collision energy of 35 eV. Identified losses reflect net, not necessarily direct, elimination of the indicated
moieties. The abbreviation “ra” denotes relative abundance (in percent). The designation “(C[XH2])2PO4HLi
1” denotes a lithiated five-membered
cyclophosphane moiety. The proposed structure of the neutral, nonlithiated cyclophosphane moiety is illustrated in the lowermost structural
diagram in pathway 2 of Figure 2.
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mass-to-charge ratio values are of low abundance in the
spectrum in Figure 4B. The combination of the three
neutral loss scans identifies both glycerolipid and
sphingolipid parents that contain the phosphocholine
head-group in tissue phospholipid mixtures.
Figure 6 illustrates that assignment of the fatty acid
composition of GPC species in tissue phospholipid
mixtures is facilitated by scanning for parents of frag-
ment ions that have lost one fatty acid substituent and
retain the other. For example, lithiated GPC species that
contain stearate yield a prominent ion at m/z 453 upon
CAD (Table 3). This ion reflects neutral loss of the other
fatty acid substituent plus trimethylamine (Table 3). As
illustrated in Figure 6A, when scanning for parents of
m/z 453 is performed with lithiated adducts of rat liver
phospholipids, the two most abundant species visual-
ized exhibit mass-to-charge ratio values consistent with
(18:0/18:2)-GPC-Li1 (m/z 792) and with (18:0/20:4)-
GPC-Li1 (m/z 816), respectively. A similar profile is
obtained by scanning for neutral loss of 343 (Figure 1B),
which reflects loss of stearic acid plus trimethylamine
from the parent ion (Table 3). The possibility that the
parent ion at m/z 816 in Figure 6A contains arachido-
nate (20:4) is supported by linked scanning for parents
of m/z 473 (Figure 6C) and for neutral loss of 475
(Figure 6D), both of which reflect arachidonate-contain-
Figure 3. Positive ion ESI tandem mass spectra of lithiated adducts of positional isomers of
asymmetrical standard glycerophosphocholine species. Panels are tandem mass spectra obtained from
CAD of [MLi1] ions of (14:0/16:0)-GPC (panel A), (16:0/14:0)-GPC (panel B), (16:0/18:1)-GPC (panel
C), or (18:1/16:0)-GPC (panel D).
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ing parents (Table 3). Both scans contain a prominent
ion at m/z 816, and, in conjunction with the scan in
Figure 6A, this indicates that the ion at m/z 816 reflects
a parent that contains both arachidonate and stearate.
Because the neutral loss scans in Figure 5 indicate that
the parent at m/z 816 also contains a phosphocholine
head-group, the parent species can be identified as
(18:0/20:4)-GPC-Li1. This assignment was confirmed
by the full-scan tandem mass spectrum produced by
CAD of m/z 816. This spectrum was identical to that in
Figure 1D.
Similarly, the possibility that the parent ion at m/z
792 in Figure 6A contains linoleate (18:2) is supported
by scanning for parents of m/z 449 (Figure 6E), an ion
generated from parents that contain linoleate (Table 3).
This scan (Figure 6E) contains a prominent ion at m/z
792, and, in conjunction with the parent ion scan in
Figure 6A and the neutral loss scans in Figure 5,
identifies the parent species as (18:0/18:2)-GPC-Li1.
This assignment was confirmed by the full-scan tandem
mass spectrum produced by CAD of m/z 792 (not
shown). Similar scanning for parents of m/z 425 (Fig-
ure 6F) or neutral loss of 315 (not shown) identifies
16:0-containing parents (Table 3) in the liver phospho-
lipid mixture, the two most abundant of which can be
assigned as (16:0/18:2)-GPC-Li1 (m/z 764) and (16:0/
20:4)-GPC-Li1 (m/z 788) by comparison of Figure 6F
with Figure 6E, C, respectively. These assignments were
supported by full-scan tandem mass spectra produced
by CAD of m/z 764 and m/z 788 (not shown).
Such tandem mass spectrometric scans also permit
identification of minor components of tissue phospho-
lipid mixtures that may not be readily appreciated from
the ESI/MS total ion current profile. For example, the
scan in Figure 6F reveals a parent with m/z 740 that
contains palmitate, although this species is poorly visu-
alized in the total ion current profile of Figure 5B. This
ion represents (16:0/16:0)-GPC-Li1, and, upon CAD
and tandem mass spectrometry, this species yields a
strong signal on scans that identify palmitate-contain-
ing parents because loss of either the sn-1 or sn-2
substituent yields the monitored product ion. Tandem
mass spectrometry scanning also facilitates distinction
among isobaric components of mixtures. For example,
Table 2. Summary of fragment ions observed in CAD tandem mass spectra of lithiated species of standard glycerophosphocholine
lipids that reflect the identities and positions of the fatty acid substituents
Standard
GPC species
MLi1
m/z
Fragment ions observed on CAD from losses of A through Ga
Ratio [C(ra)/
F(ra)]
A B C D E F G
m/z (ra) m/z (ra) m/z (ra) m/z (ra) m/z (ra) m/z (ra) m/z (ra)
14:0/14:0 684 456 (07) 450 (17) 397 (35) sym sym sym NA NA
14:0/16:0 712 484 (08) 478 (06) 425 (17) 456 (06) 450 (07) 397 (06) NA 2.8
16:0/14:0 712 456 (07) 450 (05) 397 (14) 484 (03) 478 (04) 425 (06) NA 2.3
16:0/16:0 740 484 (13) 478 (11) 425 (33) sym sym sym NA NA
16:0/18:2 764 508 (22) 502 (15) 449 (33) 484 (09) 478 (12) 425 (11) NA 2.5
16:0/18:1 766 510 (11) 504 (09) 451 (22) 484 (06) 478 (07) 425 (09) NA 2.4
16:0/20:4 788 532 (08) 526 (06) 473 (22) 484 (02) 478 (08) 425 (07) 313 (32) 3.1
18:0/20:4 816 532 (08) 526 (09) 473 (21) 512 (04) 506 (07) 453 (06) 341 (32) 3.5
aIdentification of losses A through G: A 5 R1CO2H, B 5 R1CO2Li, C 5 A1N(CH3)3, D 5 R2CO2H, E 5 R2CO2Li, F 5 D1N(CH3)3, G 5
LiPO4(CH2)2N(CH3)31R2 A C A O.
CAD tandem spectra were obtained using a collision energy of 35 eV. Identified losses reflect net, not necessarily direct, elimination of the indicated
moieties. Abbreviations “ra,” “sym,” and “NA” denote relative abundance (in percent), a symmetrical species, and not applicable, respectively.
Table 3. Summary of fragment ions from lithiated glycerophosphocholine molecular species that contain information about the fatty
acid substituents
Lithiated GPC species with the following Rx fatty acid substituents
14:0 16:0 18:0 18:1 18:2 20:4
Are parents of the ions: 397 425 453 451 449 473 from loss of RyCO2H1(CH3)3N
450 478 506 504 502 526 from loss of RyCO2Li
456 484 512 510 508 532 from loss of RyCO2H
211 239 267 — — — RxC ' O1
Undergo neutral losses of: 287 315 343 341 339 363 loss of RxCO2H1(CH3)3N
234 262 290 288 286 310 loss of RxCO2Li
228 256 284 282 289 304 loss of RxCO2H
— — — — — 475 loss of Rx A C A O1
LiPO4(CH2)2N(CH3)3
Of the two fatty acid substituents in GPC species, one is designated Rx and the other Ry. The specified losses reflect net, not necessarily direct,
elimination of the indicated moieties.
522 HSU ET AL. J Am Soc Mass Spectrom 1998, 9, 516–526
the ion at m/z 812 in Figure 4B could represent
(18:2/20:4)-PC-Li1 or (16:0/22:6)-PC-Li1. The parent
ion scan in Figure 6F indicates that this species contains
palmitate (16:0), but the scans in Figure 6E, C indicate
that the species does not contain either linoleate (18:2)
or arachidonate (20:4). This suggests that the species
represents (16:0/22:6)-GPC-Li1. This was confirmed by
scanning for parents of m/z 497, which identifies
22:6-containing precursors, and by the full-scan tandem
mass spectrum produced by CAD of the parent ion at
m/z 812 (not shown). In a similar manner, tandem
mass spectrometry scanning can establish that parent
ions are composed of isobaric components. For exam-
ple, scans for parents of m/z 473 (which identifies
20:4-containing precursors), of m/z 499 (which identi-
fies 22:5-containing precursors), and m/z 451 (which
identifies 18:1-containing precursors) indicate that the
ion at m/z 814 in Figure 4B represents both (18:1/20:
4)-PC-Li1 and of (16:0/22:5)-PC-Li1.
A summary of the GPC molecular species identified
in extracts from rat liver and brain is provided in Table
4, and a summary of fragment ions in the CAD tandem
mass spectra of the lithiated adducts of these com-
pounds is provided in Table 5.
Discussion
The ability to analyze tissue phospholipids mixtures
directly by ESI/MS/MS has simplified identification of
components of such mixtures [26–29]. Such direct anal-
yses circumvent analyte losses incurred in conventional
methods of phospholipid analysis, which have involved
two sequential HPLC steps, solvolysis, and GC/MS
analyses. Although the sensitivity and structural spec-
ificity of negative ion ESI/MS/MS is excellent for
phospholipid species that readily form negative ions,
the presence of a quaternary nitrogen moiety in GPC
species favors formation of cationic species, and tandem
mass spectra of protonated GPC species contain no
abundant ions that identify the fatty acid substituents
[18, 20–23, 27].
Our findings indicate that conversion of GPC species
to lithiated adducts facilitates their identification by
positive ion ESI/MS/MS. Lithiated adducts yield signal
similar to that of protonated adducts in terms of abso-
lute intensity and relative abundance among distinct
GPC molecular species. Lithiated adducts of GPC spe-
cies undergo more extensive fragmentation upon CAD
Figure 4. ESI/MS total positive ion current profiles of cationic
adducts of glycerophosphocholine species in rat tissue extracts.
Panels represent ESI/MS analyses of protonated (panel A) or
lithiated (panels B and C) adducts of GPC species in extracts from
rat liver (panels A and B) or brain (panel C).
Figure 5. Identification of rat liver phospholipid species that
contain a phosphocholine head-group by tandem mass spectro-
metric scanning for lithiated parents that undergo neutral losses of
the head-group or trimethylamine. Positive ion ESI/MS/MS anal-
yses of lithiated adducts of rat liver phospholipids were per-
formed to monitor neutral loss of 183 (panel A), 189 (panel B), or
59 (panel C), reflecting net elimination of [HPO4(CH2)2N(CH3)3],
[LiPO4(CH2)2N(CH3)3], or [N(CH3)3], respectively.
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than do protonated adducts, and the tandem mass
spectra of lithiated adducts include ions reflecting in-
formative losses of the fatty acid substituents and of the
phosphocholine head-group. These losses permit the
use of tandem mass spectrometry scans to identify GPC
species in tissue phospholipid mixtures and their fatty
acid substituents. For example, arachidonate-containing
parents can be identified either by scanning for parents
of the ion at m/z 473, which arises from loss of the
other fatty acid substituent plus trimethylamine, or by
scanning for parents that undergo neutral loss of 475,
reflecting net, though not direct, elimination of
[LiPO4(CH2)2N(CH3)3] and of arachidonate as a substi-
tuted ketene.
Arachidonic acid is metabolized into second messen-
ger substances, including prostaglandins, thrombox-
anes, and leukotrienes [33]. Arachidonic acid released
from tissue phospholipids may also have intrinsic sig-
naling functions, which do not require its conversion to
a metabolite [34–40]. Considerable interest has there-
fore focused on the selective loss of esterified arachid-
onate from tissue phospholipid species upon stimula-
tion of cells with activating ligands [29, 41, 42], on the
transfer of arachidonate among phospholipid head-
group classes and specific intracellular membrane com-
partments [8, 15–17, 43], and on the role of arachido-
nate-containing GPC species to serve as precursors of
the autacoid Platelet Activating Factor [44]. Facile
means for specific identification of arachidonate-con-
taining phospholipid species may be helpful in the
further study of such issues. The tandem mass spec-
trometry scanning methods described here may be
Figure 6. Identification of fatty acid substituents in glycerophosphocholine species in rat liver
phospholipids by tandem mass spectrometric scanning for parents of fragment ions that contain
specific fatty acid substituents or by scanning for parents that undergo neutral losses reflecting such
substituents. Lithiated adducts of phospholipids in a rat liver extract were analyzed by ESI/MS/MS,
and scans were performed to identify parents that yielded product ions at m/z 453 (panel A), 473
(panel C), 449 (panel E), or 425 (panel F) to identify parents that contained stearate (panel A),
arachidonate (panel C), linoleate (panel E), or palmitate (panel F). Panels B and D are scans that
identify parent ions that undergo neutral loss of 343 or 475, respectively. These scans identify stearate-
(panel B) or arachidonate-containing (panel D) GPC-Li1 parents.
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useful in this regard and serve to distinguish arachido-
nate-containing GPC species from isobaric GPC species
that occur in tissue phospholipid mixtures (e.g., 18:1/
20:4-GPC vs. 16:0/22:5-GPC or 18:0/20:4-GPC vs. 16:0/
22:4-GPC).
Because of the importance of identifying GPC spe-
cies in biological mixtures, several successful methods
have been developed for this purpose [18, 27, 45–48].
Negative ion FAB/MS/MS performed with anions gen-
erated from GPC species in the ion source (by loss of
choline, loss of the quaternary amine moiety, or loss of
a methyl group from that moiety) permits structural
identification of GPC species [18]. Structural identifica-
tion has also been achieved by negative ion ESI/
MS/MS analyses of chloride adducts of GPC species
[27]. HPLC/ESI/MS has also been used to examine
GPC species in biological extracts, and this approach
permits quantitative analyses [45, 46]. Informative frag-
mentation in positive ion mode has also been demon-
strated after thermospray ionization of intact GPC mol-
ecules [47] and after chemical ionization of diglyceride
moieties derived from GPC species [48]. Depending on
available instrumentation and analytic objectives, any
of the above approaches can yield useful information
about GPC species in biological mixtures. We believe
that positive ion ESI/MS/MS analysis of lithiated ad-
ducts of GPC species represents a potentially useful
complement to the approaches described above. Our
findings indicate that positive ion ESI/MS/MS analysis
of GPC species as lithiated adducts offers advantages
over analysis of protonated adducts and that this ap-
proach can distinguish many GPC species in biological
mixtures even under circumstances in which the avail-
able instrument configuration precludes prior LC sep-
aration or in which such separation is impractical for
other reasons.
Table 4. Molecular species of glycerophosphocholine observed in rat liver and brain by ESI tandem mass spectrometric analysis of
lithiated adducts
MLi1
m/z
Glycerophosphocholine
molecular species
Relative intensity
Liver Brain
740 16:0/16:0 0.2 39
764 16:0/18:2 90 6
766 16:0/18:1 10 100
768 16:0/18:0 0 20
788 16:0/20:4 100 25
790 (18:1/18:2)1(16:0/20:3) 28 6
792 18:0/18:2 32 10
794 18:0/18:1 1 35
812 16:0/22:6 22 12
814 (16:0/22:5)1(18:1/20:4) 15 6
816 18:0/20:4 68 14
GPC species in extracts from rat liver and brain were analyzed as lithiated adducts by positive ion ESI/MS and ESI/MS/MS. The tabulated relative
intensities of the parent ions were determined from the ESI/MS profile. The identities of the indicated species were determined from their tandem
mass spectra.
Table 5. Summary of fragment ions observed in CAD tandem mass spectra of lithiated species of glycerophosphocholine from rat
liver and brain
GPC
species MLi1
Fragment ions observed on CAD
From losses of A through Ja From acylium ions
A B C D E F G H I J R1CO
1 R2CO
1
16:0/16:0 740 681 557 551 484 478 484 478 425 425 — 239 239
16:0/18:2 764 705 581 575 508 502 484 478 449 425 — 239 263
16:0/18:1 766 707 583 577 510 504 484 478 451 425 — 239 265
16:0/20:4 768 729 605 599 532 526 484 478 473 425 313 239 —
18:1/18:2 790 731 607 601 508 502 512 506 449 453 — — —
16:0/20:3 790 731 607 601 534 528 484 478 475 425 313 239 —
18:0/18:2 792 733 609 603 508 502 512 506 449 453 — 267 263
18:0/18:1 794 735 611 605 510 504 512 506 451 453 — — —
16:0/22:5 814 755 631 625 558 552 484 478 499 425 — 239 —
18:1/20:4 814 755 631 625 532 526 510 504 473 451 339 — —
18:0/20:4 816 757 633 627 532 526 512 506 473 453 341 — —
aIdentification of losses A through J: A 5 N(CH3)3, B 5 HPO4(CH2)2N(CH3)3, C 5 LiPO4(CH2)2N(CH3)3, D 5 R1CO2H, E 5 R1CO2Li, F 5 R2CO2H, G 5
R2CO2Li, H 5 A1D, I 5 A1F, J 5 C1R2 A C A O.
The identified losses reflect net, not necessarily direct, elimination of the indicated moieties.
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